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SUMMARY
In this work we present a systematic effort to
summarize current biological pathway knowledge
concerning Rheumatoid Arthritis (RA). We are
constructing a detailed molecular map based on
exhaustive literature scanning, strict curation criteria,
re-evaluation of previously published attempts and
most importantly experts’ advice. The RA map will be
web-published in the coming months in the form of an
interactive map, using the MINERVA platform, allowing
for easy access, navigation and search of all molecular
pathways implicated in RA, serving thus, as an on line
knowledgebase for the disease. Moreover the map
could be used as a template for Omics data visualization
offering a first insight about the pathways affected in
different experimental datasets. The second goal of
the project is a dynamical study focused on synovial
fibroblasts’ behavior under different initial conditions
specific to RA, as recent studies have shown that
synovial fibroblasts play a crucial role in driving the
persistent, destructive characteristics of the disease.
Leaning on the RA knowledgebase and using the web
platform Cell Collective, we are currently building a
Boolean large scale dynamical model for the study of
RA fibroblasts’ activation.

KEYWORDS
Complex human disease; Rheumatoid arthritis;
Computational systems biology; Interactive molecular
map; Signaling network; Dynamical modelling

BODY
Protein-protein interactions are a major driving force
behind most biological processes.
They play a
pivotal role in intra- and extra-cellular functions, and
especially in the propagation of signals and cellular
regulation. Signal transduction is a fundamental process
for the communication of the cell with its environment,

comprising several interacting receptors, proteins,
enzymes, second messengers and transcription factors.
Disruption and dysregulation of these complex molecular
and signaling networks can lead to disease. Therefore,
the mapping and accurate representation of pathways
implicated is a primary but essential step for elucidating
the mechanisms underlying disease pathogenesis.
The release of various molecular maps dealing
with obesity [1], gastrin and cholecystokinin receptors
signaling [2], FceRI receptor signaling in allergy [3],
MAPKs [4], mTOR signaling [5] to name a few,
corroborates the fact that pathway assembly in the
form of network is gaining ground in systems biology.
As more scientists invest time and effort to construct
large molecular networks, there is an increasing
need for practical guidelines and a standardized
framework.
Toward this direction, initiatives have
emerge, such as The Cancer Cell Map Initiative [6],
the Atlas of Cancer Signaling Networks (http://
acsn.curie.fr) concerning cancer, and the Disease
Maps Project (http://disease-maps.org), an open,
large-scale community effort that consists of a network
of groups working together for developing best practices,
standards and tools in order to better represent disease
mechanisms.
However, as all living systems are dynamic in
nature, static representations of molecular networks
can provide useful but relatively limited understanding.
A dynamical study can reveal information about the
system’s behavior under different conditions by in
silico simulations, perturbations, hypotheses testing and
predictions. Quantitative kinetic modelling approaches
using differential or stochastic equations can provide
a detailed analysis of a network’s dynamics, but the
large number of parameters required make them less
appropriate for large scale signaling networks. In order
to address the lack of kinetic data, discrete logical
modelling can be used as an alternative way to study
the system’s qualitative dynamic behavior [7, 8].
In this work we present a systematic effort to
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of the disease and early after) (Teixeira et al., under
preparation).

summarize current biological pathway knowledge
concerning Rheumatoid Arthritis (RA), a multifactorial
autoimmune disease that causes chronic inflammation
of the synovial joints with an etiology that still remains
unclear. With the use of the software CellDesigner [9],
we are constructing a detailed molecular map based on
exhaustive literature scanning, strict curation criteria,
re-evaluation of previously published attempts [10] and
most importantly experts’ advice (Figure 1).

The RA map so far includes information derived
from more than 100 scientific papers.
It has
six distinct compartments, namely extracellular space
(with extracellular proteins), plasma membrane (with
membrane receptors and ligand proteins), cytoplasm
(with proteins, miRNAs, small molecules and the
sub-compartments of mitochondrion, Golgi apparatus
and endoplasmic reticulum), nucleus (with genes,
RNAs and transcription factors), a compartment for
the secreted molecules and a phenotype compartment
including more than ten cellular fates. It comprises more
than 400 components and a total of 324 reactions. Each
component and reaction in the map is referenced with at
least two PubMed IDs or database identifiers if inferred
from a specific database.

In 2010 Wu et al. published a detailed molecular
map concerning rheumatoid arthritis using the software
CellDesigner.
We decided to use this map as a
basis, and expand. The map has been updated with
information published after 2010 by exhaustive manual
curation and the help of data mining tools. Only
experimentally validated interactions in at least two peer
reviewed scientific publications are kept. Due to the fact
that the initial map was based on high throughput gene
expression data from 28 studies and interactions inferred
from KEGG database, all nodes and interactions are
re-evaluated carefully in an effort to limit false positives.
When validation with small scale experiments is not
possible, we keep nodes that appear in at least two
different high throughput studies. Detailed annotation
including PubMED IDs and HUGO names is also added
in the MIRIAM section of the CellDesigner file. As far as
context representation and overall structure of the map,
expert’s advice has been taken into account along with
an effort to comply with SBGN standards.

Topological analysis of the RA map using the
software Cytoscape [15] and relevant plugins reveals
unconnected or loosely connected parts that reflect
our fragmented knowledge about physical and/or
genetic interactions, posing thus obstacles in the
subsequent derivation of a reliable dynamical model. To
improve connectivity we use dedicated PPI databases
(through http://www.imexconsortium.org), pathway
databases (e.g.
KEGG, SIGNOR or REACTOME)
and the commercial software Ingenuity Pathway
Analysis (IPA, http://www.ingenuity.com) in order
to investigate potential co-players of the proteins of
interest. For the time being, we do not make use
of simulated/computationally inferred interactions or
interactions inferred from other species (i.e. mice),
restricting our search to experimentally validated data of
human origin.

The RA map will be web-published in the coming
months (a full length manuscript is under preparation)
in the form of an interactive map, using the platform
MINERVA [11], allowing for easy access, navigation
and search of all molecular pathways implicated in RA,
serving thus, as an on line knowledge base for the
disease. The user will have access to all literature
used, with detailed annotations for every component and
reaction, including PubMed IDs, and a list of identifiers
such as Uniprot, EntrezGene, Ensembl, HGNC and
RefSeq. As the map is constructed using information
from various experimental studies, the user will also
be able to opt for visualization of data with specific
cell origin, highlighting cell-specific sub-networks within
the global one. Moreover, the user will have the
possibility to spot all known drug targets, and the
corresponding drugs up to date for RA. Detailed view of
an element will allow the search for drugs, chemicals and
miRNAs targeting this particular element. Additionally,
user-provided omic datasets could be displayed as
overlay, giving a first estimation of affected pathways and
components. Lastly, the map will provide feedback about
the unmapped molecules from the dataset, allowing for
better understanding of the experimental results and for
further development of the map’s contents. We have
used public datasets from proteomic and transcriptomic
studies [12–14] to demonstrate how the map can
be used as a template for separate or simultaneous
visualization of different experimental results. The map
will also be used for the mapping of in-house data
concerning the transcriptome analysis of ten individuals
that developed RA (measurements before the onset

Characteristic features of RA include synovial
inflammation that can lead to bone erosion and
permanent deformity. It is broadly recognized that
in RA, synovial inflammation results from complex
interactions between haematopoietic and stromal cells.
Recent studies have shown that RA synovial fibroblasts
play a crucial role in driving the persistent, destructive
characteristics of the disease [16].
The second scope of the project is to model synovial
fibroblasts behavior under different initial conditions
specific to RA, in order to see if we could influence the
cellular fate (e.g. enhancing an apoptotic phenotype) or
understand what could lead to patient’s resistance to a
certain drug and how to overcome it (e.g. presence of
rescue pathways, complex feedback mechanisms).
In general, pathway representation and modelling
can be seen as two separate tasks with different
primary objectives. The first is to draw an accurate,
comprehensive diagram depicting current biological
knowledge while the second is to study the emergent
behavior of the system under different conditions.
However, a detailed, fully annotated molecular map
works as an excellent scaffold for the building of a
regulatory graph and the subsequent derivation of
the logical model. This process, that involves many
iterations, obliges one to look meticulously into the
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Figure 1: Data integration workflow. The building of a logical model is an iterative multistep process. The assembly of a
molecular map comprising biological pathways of interest and integrating information from literature and public databases could
serve as the first step. Experts’ feedback assures the quality of the map and the accuracy of the knowledge represented, along
with strict curation criteria and standards for the graphical representation. Web publication facilitates community feedback and
transforms the map in a powerful data analysis and visualization tool. The network can be further exploited using graph analysis
tools to identify important nodes and pathways, or it can serve as a scaffold for dynamical models allowing simulations. Interesting
predictions can then be experimentally tested, contributing to the validation and refinement of the map. Regular revisions are also
necessary to ensure the incorporation of novel data (Figure adapted from Niarakis et al., 2014 [3]).

way. The model will then be used to systematically
test different initial conditions and stimuli (presence or
absence of different cytokines and growth factors, and
their combinations). The aim is to predict the system’s
response to single or combined perturbations, and
identify novel targets for pharmacological intervention.

mapped pathways, spotting potentially problematic or
ambiguous aspects of the map. Model simulations
can also reveal inconsistencies concerning the global
behavior, advocating the necessity for further revisions
and refinements. Leaning on the RA knowledge base
and using the web platform Cell Collective [17], we
are currently building a Boolean dynamical model for
the study of RA fibroblasts’ activation. The model is
based on a previously published, more generic model
on fibroblasts [18] that is being modified accordingly in
order to be RA specific.

The Boolean model will be made publicly available
in Cell Collective for further contributions, simulations,
and analyses by the research community, hopefully
within 2018. The web based platform Cell Collective
allows real time simulations without the need for software
installation making the model more accessible to a wider
audience. Moreover, the platform supports annotation,
so the user can have simultaneous access to the model
description, the rules and the literature used for the rules’
inference.

In Boolean formalism, nodes represent regulatory
components (proteins, complexes, transcription factors,
etc.) and arcs represent their interactions. Each
regulatory component is associated with a Boolean
variable (taking the values 0 or 1) denoting its qualitative
concentration or level of activity (0 for absent or inactive,
1 for present or active). The future state of each node
depends on the states of its upstream regulators and is
defined by a Boolean function, expressed in the form of
a rule using the logical operators AND, OR and NOT.

Lastly, the resulting logical model for RA fibroblasts
could be further analyzed with the software GINsim [19]
and also serve as a template for the derivation of
a continuous model using the software MaBoSS [20]
allowing the computation of phenotype probabilities.

The tuning of the model includes testing against
published data and appropriate modifications
of
logical
rules
and/or
addition/deletion
of
interactions/components until it is able to reproduce well
established input-output relations (global behavior). This
process will inevitably lead back to the re-evaluation of
the molecular map and further discussions with experts
until all issues are resolved in a biologically sound
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8. Abou-Jaoudé W, Traynard P, Monteiro PT, Saez-Rodriguez J,
Helikar T, Thieffry D, et al. Logical Modeling and Dynamical
Analysis of Cellular Networks. Frontiers in Genetics. 2016;7:94.
doi:10.3389/fgene.2016.00094.
9. Funahashi A, Morohashi M, Kitano H. CellDesigner:a process
diagram editor for gene-regulatory and biochemical networks.
Biosilico. 2003;1(5):159–62. doi:10.1016/S1478-5382(03)02370-9.
10. Wu G, Zhu L, Dent JE, Nardini C. A Comprehensive Molecular
Interaction Map for Rheumatoid Arthritis. PLOS ONE. 2010
04;5(4):1–16. doi:10.1371/journal.pone.0010137.
11. Gawron P, Ostaszewski M, Satagopam V, Gebel S, Mazein A,
Kuzma M, et al. MINERVA—a platform for visualization and
curation of molecular interaction network. npj Systems Biology
and Applications. 2016;2:16020. doi:10.1038/npjsba.2016.20.
12. Dasuri K, Antonovici M, Chen K, Wong K, Standing K, Ens W, et al.
The synovial proteome: analysis of fibroblast-like
synoviocytes. Arthritis Research and Therapy. 2004;6(2):R161.
doi:10.1186/ar1153.
13. Teixeira VH, Olaso R, Martin-Magniette ML, Lasbleiz S, Jacq L,
Oliveira CR, et al. Transcriptome Analysis Describing New
Immunity and Defense Genes in Peripheral Blood
Mononuclear Cells of Rheumatoid Arthritis Patients. PLoS
ONE. 2009;4(8):0006803. doi:10.1371/journal.pone.0006803.
14. Heruth DP, Gibson M, Grigoryev DN, Zhang LQ, Ye SQ. RNA-seq
analysis of synovial fibroblasts brings new insights into
rheumatoid arthritis. Cell and bioscience. 2012;2(1):43.
doi:10.1186/2045-3701-2-43.
15. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D,
et al. Cytoscape: A Software Environment for Integrated
Models of Biomolecular Interaction Networks. Genome
Research. 2003;13(11):2498–2504. doi:10.1101/gr.1239303.
16. Juarez M, Filer A, Buckley C. Fibroblasts as therapeutic targets
in rheumatoid arthritis and cancer. Swiss Medical Weekly.
2012;142:w13529. doi:10.4414/smw.2012.13529.
17. Helikar T, Kowal B, McClenathan S, Bruckner M, Rowley T,
Madrahimon A, et al. The Cell Collective: Toward an open and
collaborative approach to systems biology. BMC Systems
Biology. 2012;6(96). doi:10.1186/1752-0509-6-96.
18. Helikar T, Konvalina J, Heidel J, Rogers JA. Emergent
decision-making in biological signal transduction networks.
Proceedings of the National Academy of Sciences of the United
States of America. 2008;105(6):1913–1918.
doi:10.1073/pnas.0705088105.
19. Chaouiya C, Naldi A, Thieffry D. Logical Modelling of Gene
Regulatory Networks with GINsim. In: Bacterial Molecular
Networks: Methods and Protocols. New York, NY: Springer New
York; 2012. p. 463–479. doi:10.1007/978-1-61779-361-5 23.

4

View publication stats

